(Q35146833)

6 August 2017

title

Regression of established tumors and metastases by potent vascular endothelial growth factor blockade (English)

1 reference

6 August 2017

0 references

Jianzhong Huang

1

1 reference

6 August 2017

Jason S Frischer

2

1 reference

6 August 2017

Anna Serur

3

1 reference

6 August 2017

Angela Kadenhe

4

1 reference

6 August 2017

Akiko Yokoi

5

1 reference

6 August 2017

Kimberly W McCrudden

6

1 reference

6 August 2017

Tamara New

7

1 reference

6 August 2017

Kathleen O'Toole

8

1 reference

6 August 2017

Stephanie Zabski

9

1 reference

6 August 2017

John S Rudge

10

1 reference

6 August 2017

Jocelyn Holash

11

1 reference

6 August 2017

George D Yancopoulos

12

1 reference

6 August 2017

Darrell J Yamashiro

13

1 reference

6 August 2017

Jessica J Kandel

14

1 reference

6 August 2017

language of work or name

English

0 references

publication date

12 June 2003

1 reference

Proceedings of the National Academy of Sciences of the United States of America

6 August 2017

published in

1 reference

6 August 2017

volume

100

1 reference

6 August 2017

issue

13

1 reference

6 August 2017

page(s)

7785-7790

1 reference

Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

VEGF-Trap: a VEGF blocker with potent antitumor effects

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

In vivo prediction of vascular susceptibility to vascular susceptibility endothelial growth factor withdrawal: magnetic resonance imaging of C6 rat glioma in nude mice.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=164665

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors

27 September 2018

1 reference

12 December 2020

Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor

1 reference

12 December 2020

Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells

1 reference

12 December 2020

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.1432908100

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference